Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video
Go back to Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.51 +0.05 (2.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.46 | 52 Week High | $9.58 | |||
| Open | $2.46 | 52 Week Low | $2.34 | |||
| Day High | $2.64 | P/E | N/A | |||
| Day Low | $2.40 | EPS | $-0.34 | |||
| Volume | 270,067 | |||||

